PortfoliosLab logo
PODD vs. DXCM
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between PODD and DXCM is 0.46, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

PODD vs. DXCM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Insulet Corporation (PODD) and DexCom, Inc. (DXCM). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

PODD:

1.87

DXCM:

-0.60

Sortino Ratio

PODD:

3.11

DXCM:

-0.38

Omega Ratio

PODD:

1.42

DXCM:

0.93

Calmar Ratio

PODD:

1.83

DXCM:

-0.51

Martin Ratio

PODD:

14.50

DXCM:

-0.82

Ulcer Index

PODD:

6.10%

DXCM:

39.25%

Daily Std Dev

PODD:

40.64%

DXCM:

58.58%

Max Drawdown

PODD:

-90.28%

DXCM:

-94.61%

Current Drawdown

PODD:

-1.66%

DXCM:

-47.50%

Fundamentals

Market Cap

PODD:

$22.85B

DXCM:

$33.52B

EPS

PODD:

$5.59

DXCM:

$1.33

PE Ratio

PODD:

58.09

DXCM:

64.27

PEG Ratio

PODD:

8.13

DXCM:

1.32

PS Ratio

PODD:

10.39

DXCM:

8.08

PB Ratio

PODD:

17.03

DXCM:

14.82

Total Revenue (TTM)

PODD:

$2.03B

DXCM:

$4.15B

Gross Profit (TTM)

PODD:

$1.55B

DXCM:

$2.46B

EBITDA (TTM)

PODD:

$428.10M

DXCM:

$889.80M

Returns By Period

In the year-to-date period, PODD achieves a 24.39% return, which is significantly higher than DXCM's 9.91% return. Over the past 10 years, PODD has outperformed DXCM with an annualized return of 27.58%, while DXCM has yielded a comparatively lower 17.38% annualized return.


PODD

YTD

24.39%

1M

31.58%

6M

24.85%

1Y

73.41%

5Y*

10.08%

10Y*

27.58%

DXCM

YTD

9.91%

1M

24.66%

6M

12.65%

1Y

-34.93%

5Y*

-3.79%

10Y*

17.38%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

PODD vs. DXCM — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PODD
The Risk-Adjusted Performance Rank of PODD is 9595
Overall Rank
The Sharpe Ratio Rank of PODD is 9595
Sharpe Ratio Rank
The Sortino Ratio Rank of PODD is 9595
Sortino Ratio Rank
The Omega Ratio Rank of PODD is 9494
Omega Ratio Rank
The Calmar Ratio Rank of PODD is 9292
Calmar Ratio Rank
The Martin Ratio Rank of PODD is 9797
Martin Ratio Rank

DXCM
The Risk-Adjusted Performance Rank of DXCM is 2323
Overall Rank
The Sharpe Ratio Rank of DXCM is 1818
Sharpe Ratio Rank
The Sortino Ratio Rank of DXCM is 2525
Sortino Ratio Rank
The Omega Ratio Rank of DXCM is 2121
Omega Ratio Rank
The Calmar Ratio Rank of DXCM is 1818
Calmar Ratio Rank
The Martin Ratio Rank of DXCM is 3232
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

PODD vs. DXCM - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Insulet Corporation (PODD) and DexCom, Inc. (DXCM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current PODD Sharpe Ratio is 1.87, which is higher than the DXCM Sharpe Ratio of -0.60. The chart below compares the historical Sharpe Ratios of PODD and DXCM, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

PODD vs. DXCM - Dividend Comparison

Neither PODD nor DXCM has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

PODD vs. DXCM - Drawdown Comparison

The maximum PODD drawdown since its inception was -90.28%, roughly equal to the maximum DXCM drawdown of -94.61%. Use the drawdown chart below to compare losses from any high point for PODD and DXCM. For additional features, visit the drawdowns tool.


Loading data...

Volatility

PODD vs. DXCM - Volatility Comparison

Insulet Corporation (PODD) has a higher volatility of 20.88% compared to DexCom, Inc. (DXCM) at 17.14%. This indicates that PODD's price experiences larger fluctuations and is considered to be riskier than DXCM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

PODD vs. DXCM - Financials Comparison

This section allows you to compare key financial metrics between Insulet Corporation and DexCom, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


200.00M400.00M600.00M800.00M1.00B1.20B20212022202320242025
569.00M
1.04B
(PODD) Total Revenue
(DXCM) Total Revenue
Values in USD except per share items

PODD vs. DXCM - Profitability Comparison

The chart below illustrates the profitability comparison between Insulet Corporation and DexCom, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

55.0%60.0%65.0%70.0%20212022202320242025
71.9%
56.9%
(PODD) Gross Margin
(DXCM) Gross Margin
PODD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Insulet Corporation reported a gross profit of 409.00M and revenue of 569.00M. Therefore, the gross margin over that period was 71.9%.

DXCM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, DexCom, Inc. reported a gross profit of 589.00M and revenue of 1.04B. Therefore, the gross margin over that period was 56.9%.

PODD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Insulet Corporation reported an operating income of 88.80M and revenue of 569.00M, resulting in an operating margin of 15.6%.

DXCM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, DexCom, Inc. reported an operating income of 133.70M and revenue of 1.04B, resulting in an operating margin of 12.9%.

PODD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Insulet Corporation reported a net income of 35.40M and revenue of 569.00M, resulting in a net margin of 6.2%.

DXCM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, DexCom, Inc. reported a net income of 105.40M and revenue of 1.04B, resulting in a net margin of 10.2%.